Skip to content

Lovesac LOVE R&D credit carryforward

R&D credit carryforward at other companies

Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
$850K+49.9%
Aptera Motors Corp.
 logo
Aptera Motors Corp. SEV
$3.87M+24.1%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$63.46M+1.8%
electroCore, Inc. logo
electroCore, Inc.ECOR
$2.68M+29.4%
Richtech Robotics Inc. logo
Richtech Robotics Inc.RR
$7K0.0%
AZZ logo
AZZAZZ
$970K-80.8%

Other financials

Income statement

See full
Revenue$138.2M-0.1%
Gross profit$72.0M-3.2%
Operating income-$17.4M-16.2%
Net income-$11.1M-2.3%
EPS (diluted)-$0.76-4.1%

Balance sheet

See full
Cash & equivalents$57.0M+112%
Total debt$190.9M-0.4%
Total equity$205.5M+2.1%
Total assets$501.0M+3.6%

Cash flow

See full
Operating cash flow-$35.4M+14.6%
CapEx$5.0M-41.4%
Free cash flow-$40.4M+19.2%

Valuation

See full
Market cap$244.32M-8.7%
Enterprise value$378.19M-12.5%
P/E64.1×+44.5×
P/S0.4×0.0×

Profitability

See full
Gross margin56.1%-2.2pp
Operating margin0.4%-2.0pp
Net margin0.5%-1.4pp
FCF margin5.1%+3.8pp

Returns & leverage

See full
Return on equity1.9%-4.9pp
Debt / equity0.9×0.0×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by Lovesac in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch.

The official record: Lovesac’s 10-K, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lovesac's r&d credit carryforward.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lovesac's r&d credit carryforward?
Lovesac (LOVE) reported r&d credit carryforward of $181K in Q4 2025.
What does r&d credit carryforward mean?
This asset represents the value of research and development tax credits that have been earned but not yet utilized to offset future tax liabilities. It provides a potential future cash flow benefit by reducing the company's effective tax rate in profitable years. This metric highlights the company's investment in innovation and its ability to leverage tax incentives.